A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.
- 1 November 1980
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 10 (5), 491-497
- https://doi.org/10.1111/j.1365-2125.1980.tb01794.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- On the Metabolism of Lidocaine I. The Properties of the Enzyme System responsible for the oxidative Metabolism of Lidocaine.Acta Pharmacologica et Toxicologica, 2009
- Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene TreatmentXenobiotica, 1979
- Factors influencing antipyrine elimination.British Journal of Clinical Pharmacology, 1977
- Lidocaine Metabolism in Normal and Phenobarbital-pretreated DogsAnesthesiology, 1972
- Influence of Route of Administration on Drug AvailabilityJournal of Pharmaceutical Sciences, 1972
- GENETIC CONTROL OF DRUG LEVELS AND OF THE INDUCTION OF DRUG‐METABOLIZING ENZYMES IN MAN: INDIVIDUAL VARIABILITY IN THE EXTENT OF ALLOPURINOL AND NORTRIPTYLINE INHIBITION OF DRUG METABOLISMAnnals of the New York Academy of Sciences, 1971
- Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in ManCirculation, 1971
- PLASMA LIDOCAINE LEVELS IN PATIENTS TREATED WITH POTENTIAL INDUCERS OF MICROSOMAL ENZYMESActa Anaesthesiologica Scandinavica, 1970
- Genetic control of dicumarol levels in manJCI Insight, 1968
- On the Metabolism of Lidocaine II. The Biotransformation of Lidocaine.Acta Pharmacologica et Toxicologica, 1961